BridgeMD
New treatment option for Hidradenitis Suppurativa
Official title Battlefield Acupuncture for Pain in Hidradenitis Suppurativa
ClinicalTrials.gov ID: NCT04218422
What this study is testing
- What it's testing
- The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- age 18 years or older
- dermatologist-confirmed diagnosis of hidradenitis suppurativa
- significant pain from hidradenitis at least twice weekly
- stable treatment regimen for hidradenitis during study period
You likely can't join if
- disease or disfigurement of the ear that prevents battlefield acupuncture of the ears
- other chronic pain that will interfere with the ability to rate hidradenitis pain
The study team makes the final eligibility decision.
Where it's taking place
- Dearborn, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dearborn, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.